Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity

作者: Lana L. Jackson , Zane Wade , Richard B. Hessler , Rafik Abdelsayed , Jeremy B. Rogers

DOI: 10.1097/MLG.0B013E318033C810

关键词:

摘要: Introduction: Decreased expression of syndecan-1 has been reported in dysplasia and squamous cell carcinoma (SCCA) the oral cavity appears to correlate with decreasing histological differentiation poor clinical outcome. Assays date have utilized manual microscopic analysis qualitative grading immunohistochemical staining intensity, which may introduce observer bias. We evaluated cavity, using a novel automated cellular imaging system that incorporates both intensity as well percentage positively stained cells yield quantitative value for expression. Materials Methods: performed an image system. analyzed specimens from cases mild (N = 55), moderate 38), severe 25), situ (CIS) 43), SCCA 45), normal mucosal epithelium 21) positive control. The were further subdivided by degree differentiation. retrospectively reviewed patient charts identify tumor stage at diagnosis, recurrence, disease-specific survival. Results: Syndecan-1 was significantly greater controls than mild, moderate, or dysplasia, CIS, invasive (P < .05). did not differ among CIS SCCA. There no significant difference between patients evidence disease 3 years follow-up local, regional, distant recurrence. Conclusions: does appear be useful marker prognostic indicator cavity. search suitable reliable biological aggressiveness is ongoing.

参考文章(16)
Jaakko O. Pulkkinen, Marjatta Penttinen, Markku Jalkanen, Pekka Klemi, Reidar Grenman, Syndecan-1: A New Prognostic Marker in Laryngeal Cancer Acta Oto-Laryngologica. ,vol. 117, pp. 312- 315 ,(1997) , 10.3109/00016489709117794
Shuji Mikami, Kenichi Ohashi, Yutaka Usui, Tetsuo Nemoto, Ken-ichi Katsube, Masaki Yanagishita, Motowo Nakajima, Kyouichi Nakamura, Morio Koike, Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Japanese Journal of Cancer Research. ,vol. 92, pp. 1062- 1073 ,(2001) , 10.1111/J.1349-7006.2001.TB01061.X
Janusz Klatka, Syndecan-1 expression in laryngeal cancer European Archives of Oto-rhino-laryngology. ,vol. 259, pp. 115- 118 ,(2002) , 10.1007/S00405-001-0429-7
Hideo Kurokawa, Shinobu Matsumoto, Tomoyuki Murata, Yoshihiro Yamashita, Taiki Tomoyose, Min Zhang, Hiroshi Fukuyama, Tetsu Takahashi, Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. Journal of Oral Pathology & Medicine. ,vol. 32, pp. 513- 521 ,(2003) , 10.1034/J.1600-0714.2003.00117.X
Y. Ro, T. Muramatsu, K. Shima, Y. Yajima, T. Shibahara, H. Noma, M. Shimono, Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue International Journal of Oral and Maxillofacial Surgery. ,vol. 35, pp. 252- 257 ,(2006) , 10.1016/J.IJOM.2005.06.020
A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, M. J. Thun, Cancer statistics, 2005. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 10- 30 ,(2005) , 10.3322/CANJCLIN.55.1.10
Perkins Mukunyadzi, Kela Liu, Ehab Y Hanna, James Y Suen, Chun-Yang Fan, Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Modern Pathology. ,vol. 16, pp. 796- 801 ,(2003) , 10.1097/01.MP.0000081731.17549.53
Henry T. Hoffman, Lucy Hynds Karnell, Gerry F. Funk, Robert A. Robinson, Herman R. Menck, The National Cancer Data Base Report on Cancer of the Head and Neck Archives of Otolaryngology-head & Neck Surgery. ,vol. 124, pp. 951- 962 ,(1998) , 10.1001/ARCHOTOL.124.9.951
A Anttonen, M Kajanti, P Heikkilä, M Jalkanen, H Joensuu, Syndecan-1 expression has prognostic significance in head and neck carcinoma. British Journal of Cancer. ,vol. 79, pp. 558- 564 ,(1999) , 10.1038/SJ.BJC.6690088